Biomarkers · Inflammation
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
Lower values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
suPAR and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Published risk of death2.03×per doubling of 5-year suPAR (95% CI 1.22–3.37) · Danish population-based Inter99 study; paired suPAR at baseline and 5-year visit, mortality follow-up after 5-year visit
Sources
- Risk curve: Haupt TH 2019 (PMID 30679937): all-cause HR 2.03 (1.22-3.37) per doubling of 5-year suPAR. Scaled to published population values.
- Haupt TH, Rasmussen LJH, Kallemose T, et al. Healthy lifestyles reduce suPAR and mortality in a Danish general population study. Immun Ageing. 2019;16:1.
Map Soluble Urokinase Plasminogen Activator Receptor (suPAR) against another biomarker.
Related markers: Alpha-1-Antichymotrypsin (AACT) · Alpha-1-Antitrypsin (AAT) · Antinuclear Antibodies (ANA) · CD4:CD8 T-Cell Ratio · CD8+ T-Cell Count · Erythrocyte Sedimentation Rate (ESR) · Fibrinogen · Growth Differentiation Factor-15 (GDF-15)